Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy J Craig

Showing results (151-160 of 176) with videos related to

Pageof 18
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 3, 2010
Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacksJonathan A Bernstein, Bruce Ritchie, Robyn J Levy, et al.
Allergy and Asthma Proceedings|January 26, 2011
Hereditary angioedema: Validation of the end point time to onset of relief by correlation with symptom intensityJonathan A Bernstein, Bruce Ritchie, Robyn J Levy, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 14, 2020
Association Between Self-Reported Dental Hygiene Practices and Dental Procedure-Related Recurrent Angioedema Attacks in HAE Subjects: A Multicenter SurveyUmesh Singh, William R Lumry, Paula Busse, et al.
The Lancet. Haematology|May 6, 2024
Garadacimab for hereditary angioedema attack prevention: long-term efficacy, quality of life, and safety data from a phase 2, randomised, open-label extension studyTimothy J Craig, Donald S Levy, Avner Reshef, et al.
Advances in Therapy|June 10, 2026
Long-Term Integrated Safety and Efficacy of Garadacimab for Hereditary Angioedema ProphylaxisTimothy J Craig, Mar Guilarte, Huamin Henry Li, et al.
Allergy|November 27, 2023
A phase 2 open-label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedemaRemy S Petersen, Laura Bordone, Marc A Riedl, et al.
American Journal of Respiratory and Critical Care Medicine|December 3, 2005
beta-Adrenergic receptor polymorphisms and response to salmeterolMichael E Wechsler, Erik Lehman, Stephen C Lazarus, et al.
The Journal of Allergy and Clinical Immunology|April 5, 2005
Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroidsAaron Deykin, Stephen C Lazarus, John V Fahy, et al.
American Journal of Respiratory and Critical Care Medicine|September 16, 2006
Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthmaAaron Deykin, Michael E Wechsler, Homer A Boushey, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|April 16, 2014
A consensus parameter for the evaluation and management of angioedema in the emergency departmentJoseph J Moellman, Jonathan A Bernstein, Christopher Lindsell, et al.
Pageof 18

Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 3, 2010
Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacksJonathan A Bernstein, Bruce Ritchie, Robyn J Levy, et al.
Allergy and Asthma Proceedings|January 26, 2011
Hereditary angioedema: Validation of the end point time to onset of relief by correlation with symptom intensityJonathan A Bernstein, Bruce Ritchie, Robyn J Levy, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 14, 2020
Association Between Self-Reported Dental Hygiene Practices and Dental Procedure-Related Recurrent Angioedema Attacks in HAE Subjects: A Multicenter SurveyUmesh Singh, William R Lumry, Paula Busse, et al.
The Lancet. Haematology|May 6, 2024
Garadacimab for hereditary angioedema attack prevention: long-term efficacy, quality of life, and safety data from a phase 2, randomised, open-label extension studyTimothy J Craig, Donald S Levy, Avner Reshef, et al.
Advances in Therapy|June 10, 2026
Long-Term Integrated Safety and Efficacy of Garadacimab for Hereditary Angioedema ProphylaxisTimothy J Craig, Mar Guilarte, Huamin Henry Li, et al.
Allergy|November 27, 2023
A phase 2 open-label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedemaRemy S Petersen, Laura Bordone, Marc A Riedl, et al.
American Journal of Respiratory and Critical Care Medicine|December 3, 2005
beta-Adrenergic receptor polymorphisms and response to salmeterolMichael E Wechsler, Erik Lehman, Stephen C Lazarus, et al.
The Journal of Allergy and Clinical Immunology|April 5, 2005
Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroidsAaron Deykin, Stephen C Lazarus, John V Fahy, et al.
American Journal of Respiratory and Critical Care Medicine|September 16, 2006
Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthmaAaron Deykin, Michael E Wechsler, Homer A Boushey, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|April 16, 2014
A consensus parameter for the evaluation and management of angioedema in the emergency departmentJoseph J Moellman, Jonathan A Bernstein, Christopher Lindsell, et al.
Pageof 18